Clinical Briefings™: Assessing and Managing Ocular Health in Glaucoma

Clinical Briefings™: Assessing and Managing Ocular Health in Glaucoma is organized by Physicians' Education Resource, LLC (PER).

Release Date: January 29, 2020
Expiration Date: January 29, 2021

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
As a leading cause of blindness, glaucoma requires critical diagnostic and treatment skills among ophthalmologists and other eye care professionals. Topical agents with a variety of mechanisms of action are available for lowering intraocular pressure (IOP), as are procedures, and choosing the appropriate option for each patient can be challenging. Emerging data on potential harms from the topical preservative benzalkonium chloride (BAK) can make treatment selection more complex for some patients. This program provides an overview of the glaucoma treatment landscape, including IOP target goals; surgical and medical options, including preservative-free choices; and emerging therapies. Accompanying audio from a glaucoma expert provides additional detail and clinical perspective.

Benefits of Participating:
This activity will better prepare you to:
• Weigh factors in setting treatment goals for patients with glaucoma
• Compare and contrast the benefits and risks of currently available glaucoma treatments, including preservative-free topical medications
• Track the development of emerging glaucoma therapies.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Characterize current intraocular agents used to treat glaucoma according to efficacy, safety, and preservative content
• Describe the common effects of long-term BAK on the conjunctiva, cornea, lens, and trabecular meshwork
• Evaluate the efficacy and safety of alternative preservatives and preservative-free formulations for the management of intraocular pressure